GlaxoSmithKline begins search for new ceo to succeed embattled Sir Andrew Witty as investors call for drugs giant to be split up
GlaxoSmithKline has kicked off the search for a chief executive to succeed embattled Sir Andrew Witty.
With the drugs giant facing pressure from powerful shareholders, it is understood the board has started succession planning.
Witty, who was paid £3.9million in 2014, joined Glaxo in 1985 and took over as chief executive in May 2008 after Jean-Pierre Garnier retired.
Under pressure: GlaxoSmithKline boss is looking for a new boss to replace Sir Andrew Witty (pictured)
His future is in the hands of chairman Sir Philip Hampton, the former Royal Bank of Scotland chairman who took the helm in May.
Follow us: @MailOnline on Twitter | DailyMail on Facebook